NCT00496236 Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00490282 A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer Status COMPLETED Phase NA
NCT00490061 Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy Status TERMINATED Phase PHASE2
NCT00486304 Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy Status COMPLETED Phase PHASE1
NCT00485485 Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer Status COMPLETED Phase PHASE2
NCT00483821 A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC Status COMPLETED Phase N/A
NCT00483639 Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer Status COMPLETED Phase N/A
NCT00482872 Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer Status COMPLETED Phase N/A
NCT00468169 Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00466856 Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors Status TERMINATED Phase PHASE2
NCT00465725 A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT00462735 Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00453336 Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract Status COMPLETED Phase PHASE2
NCT00448552 Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00448240 Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT00446446 PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) Status COMPLETED Phase PHASE2
NCT00442520 Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy Status COMPLETED Phase N/A